These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2666743)

  • 1. Detection of altered H-ras proteins in human tumors using western blot analysis.
    Joyce AD; D'Emilia JC; Steele G; Libertino JA; Silverman ML; Summerhayes IC
    Lab Invest; 1989 Aug; 61(2):212-8. PubMed ID: 2666743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential and novel activation of H-ras in human bladder carcinomas.
    Visvanathan KV; Pocock RD; Summerhayes IC
    Oncogene Res; 1988; 3(1):77-86. PubMed ID: 3144694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of active ras oncogenes in human bladder cancers associated with schistosomiasis.
    Fujita J; Nakayama H; Onoue H; Rhim JS; el-Bolkainy MN; el-Aaser AA; Kitamura Y
    Jpn J Cancer Res; 1987 Sep; 78(9):915-20. PubMed ID: 3117747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of the Grb2 and son of sevenless (Sos) proteins in human bladder cancer cell lines.
    Watanabe T; Shinohara N; Moriya K; Sazawa A; Kobayashi Y; Ogiso Y; Takiguchi M; Yasuda J; Koyanagi T; Kuzumaki N; Hashimoto A
    IUBMB Life; 2000 Apr; 49(4):317-20. PubMed ID: 10995035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
    Kyprianou N; Isaacs JT
    Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of monoclonal antibody R256, specific for activated ras p21 with arginine at 12, and analysis of breast carcinoma of v-Harvey-ras transgenic mouse.
    Pullano TG; Sinn E; Carney WP
    Oncogene; 1989 Aug; 4(8):1003-8. PubMed ID: 2474786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells.
    Chi S; Kitanaka C; Noguchi K; Mochizuki T; Nagashima Y; Shirouzu M; Fujita H; Yoshida M; Chen W; Asai A; Himeno M; Yokoyama S; Kuchino Y
    Oncogene; 1999 Apr; 18(13):2281-90. PubMed ID: 10327074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
    Ward JM; Perantoni AO; Santos E
    Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proteomic approach for dissecting H-Ras signaling networks in NIH/3T3 mouse embryonic fibroblast cells.
    Park JW; Kim S; Bahk YY
    Proteomics; 2006 Apr; 6(8):2433-43. PubMed ID: 16612794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting Ras prenylation increases the radiosensitivity of human tumor cell lines with activating mutations of ras oncogenes.
    Bernhard EJ; McKenna WG; Hamilton AD; Sebti SM; Qian Y; Wu JM; Muschel RJ
    Cancer Res; 1998 Apr; 58(8):1754-61. PubMed ID: 9563495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene.
    Dartsch PC; Ritter M; Häussinger D; Lang F
    Eur J Cell Biol; 1994 Apr; 63(2):316-25. PubMed ID: 8082656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformation.
    Araujo JC; Doniger J; Stöppler H; Sadaie MR; Rosenthal LJ
    Oncogene; 1997 Feb; 14(8):937-43. PubMed ID: 9050993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence and possible role of c-ras and nuclear (c-fos and c-jun) proto-oncogene products in preimplantation embryonic development in mice.
    Ahmad K; Naz RK
    Mol Reprod Dev; 1993 Nov; 36(3):297-306. PubMed ID: 8286110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of colorectal cancer growth using an adenovirus vector expressing an antisense K-ras RNA.
    Nakano M; Aoki K; Matsumoto N; Ohnami S; Hatanaka K; Hibi T; Terada M; Yoshida T
    Mol Ther; 2001 Apr; 3(4):491-9. PubMed ID: 11319909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal preservation of p21 ras immunoreactivity and morphology in paraffin-embedded tissue.
    Going JJ; Williams AR; Wyllie AH; Anderson TJ; Piris J
    J Pathol; 1988 Jul; 155(3):185-90. PubMed ID: 3045276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody reactive with an activated ras protein expressing valine at position 12.
    Carney WP; Hamer P; Petit D; Wolfe H; Cooper G; Lefebvre M; Rabin H
    J Cell Biochem; 1986; 32(3):207-14. PubMed ID: 3536974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors.
    Jamieson S; Alexiadis M; Fuller PJ
    Gynecol Oncol; 2004 Dec; 95(3):603-9. PubMed ID: 15581971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered extracellular matrices influence cellular processes and nuclear matrix organizations of overlying human bladder urothelial cells.
    Gordon JN; Shu WP; Schlussel RN; Droller MJ; Liu BC
    Cancer Res; 1993 Oct; 53(20):4971-7. PubMed ID: 8402687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.
    Garcia-España A; Salazar E; Sun TT; Wu XR; Pellicer A
    Cancer Res; 2005 Feb; 65(4):1150-7. PubMed ID: 15734997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.